• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

5. BioMed e-Series

5. BioMed e-Series

48 Volumes of Curated Biomedical Intelligence (English & Spanish Editions)

The BioMed e-Series represents one of LPBI Group’s most significant achievements — a comprehensive collection of 48 expertly curated e-Books (including bundled editions) spanning the core domains of pharmaceutical, medical, life sciences, and biomedical research.

Key Highlights

  • Published on Amazon Kindle and available in both English and Spanish editions
  • Over 151,000 page downloads recorded to date
  • Each volume is built from the Journal’s high-quality curated content and organized by therapeutic area
  • Serves as a rich, structured multimodal training resource (text + images + references)

Strategic Role in 2026 & Beyond

The e-Series is a cornerstone of our 9 GB multimodal maxi-vault. It provides deep, domain-specific knowledge that powers multiple Small Language Models (SLMs) and contributes directly to our 13 Hidden Gems. The bilingual nature and expert curation make it particularly valuable for global AI applications in healthcare.

This collection is not merely a library — it is a trainable, high-provenance intellectual asset designed to accelerate causal reasoning and multimodal intelligence for the next generation of AI in Health.

Details on LPBI Group’s BioMed e-Series consists of 48 e-Books:

Between June 2013 and February 2021, LPBI Group’s team published in the English-language Edition eighteen electronic medical books covering five medical specialties:

  • Series A: Cardiovascular Diseases – Six volumes
  • Series B: Frontiers in Genomics – Two volumes
  • Series C: Cancer & Oncology – Two volumes
  • Series D: Immunology – Four volumes [volume 2&3 published in one book]
  • Series E: Patient-Centered Medicine & Precision Medicine – Four volumes

These e-books, including 2,728 scientific articles curated and authored by biomedical experts and medical professionals pursuing the quest to make the latest research available to healthcare professionals and accessible to the global community of biological scientists and practicing physicians and medical students.

URLs on Amazon.com for all the 37 e-Books are found in

[23 (English: 17+5) +24 (Spanish: 19+5) +1 = 48]

https://www.amazon.com/s?k=Aviva+Lev-Ari&i=digital-text&rh=n%3A133140011&ref=nb_sb_noss

For URL of each of the 47 books, See

https://pharmaceuticalintelligence.com/five-bilingual-biomed-e-series/

For URL of for the 48th Book, Library of Podcasts, See

https://www.amazon.com/dp/B0CQXL5MTW

The 2026 & Beyond NEW life of these books is as TRAINABLE Text and images for Multimodal Foundation Model in Healthcare [MFMH].

  • Using an “Invented here” Autonomous Journal Article Updating System [AJAUS] – an Integrated Architecture (AJAUS + OpenClaw +NemoClaw) will be used to produce 2nd Editions to each e-Book in the near future.

URLs for the English-language Edition by e-Series:

18 Volumes + 5 Book Bundles at the Series Level = 23 distinctive URLs

  • These are the distinctive URLs at the Series Level

Series A: Cardiovascular Diseases ($515)

https://www.amazon.com/gp/product/B07P981RCS?ref_=dbs_p_mng_rwt_ser_shvlr&storeType=ebooks

Series B: Frontiers in Genomics ($200)

https://www.amazon.com/gp/product/B0BSDPG2RX?ref_=dbs_p_pwh_rwt_anx_b_lnk&storeType=ebooks

Series C: Cancer & Oncology ($175)

https://www.amazon.com/gp/product/B0BSDWVB3H?ref_=dbs_p_mng_rwt_ser_shvlr&storeType=ebooks

Series D: Immunology ($325)

https://www.amazon.com/gp/product/B08VVWTNR4?ref_=dbs_p_pwh_rwt_anx_b_lnk&storeType=ebooks

Series E: Patient-Centered Medicine ($274)

https://www.amazon.com/gp/product/B0BSDW2K6C?ref_=dbs_p_mng_rwt_ser_shvlr&storeType=ebooks

 

URLs for the Spanish-language Edition by e-Series:

19 volumes + 5 Book Bundles = 24 distinctive URLs

  • These are the distinctive URLs at the Series Level

Serie A: Enfermedades cardiovasculares ($385)

https://www.amazon.com/gp/product/B0BPR9L1ZX?ref_=dbs_p_pwh_rwt_anx_a_lnk

Serie B: Fronteras de la investigación genómica ($305)

https://www.amazon.com/dp/B0BQGZYZVT?binding=kindle_edition&ref=dbs_dp_rwt_sb_pc_tuk

Serie C: Cáncer y la oncología ($231)

https://www.amazon.com/dp/B0BQHMRK3C?binding=kindle_edition&ref=dbs_dp_rwt_sb_pc_tukn

Serie D: Biomedicina. Metabolómica, inmunología, enfermedades infecciosas, genómica reproductiva y endocr ($268)

https://www.amazon.com/dp/B0BR8P5TST

Serie E: Medicina centrada en el paciente ($217)

https://www.amazon.com/dp/B0BRGMCM8Q?binding=kindle_edition&ref=dbs_dp_rwt_sb_pc_tukn

 

Chronological Year of Publication, Book Cover Page and electronic Table of Contents (eTOCs), see

https://pharmaceuticalintelligence.com/biomed-e-books/

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading…

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,056 other subscribers
  • Recent Posts

    • Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983. January 31, 2026
    • 2026 World Economic Forum, 1/19 – 1/23/2026, Davos, Switzerland, LPBI Group’s KOLs interpretation of AI in Health Videos January 24, 2026
    • Evolving LPBI Group’s Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality January 12, 2026
    • Aviva Lev-Ari, PhD, RN – Biography ->> Grokepedia Entry January 11, 2026
    • List of Articles included in the Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com January 10, 2026
    • The youngest leader in AI in Health: Tanishq Mathew Abraham, Ph.D. (@iScienceLuvr) January 8, 2026
    • 2026 Grok Multimodal Causal Reasoning on Proprietary Cariovascular Corpus: From 2021 Wolfram NLP Baseline to Thousands of Novel Relationships – A Second Head-to-Head Validation of LPBI’s Domain-Aware Training Advantage January 6, 2026
    • Workflow for Dynamic Linkage and Transition between two Authoring Systems: LPBI Group’s WordPress.com Multi-Authors Authoring System and Microsoft PowerPoint product for Slide show presentation – Part 10.1 in Composition of Methods January 6, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d